A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo

[1]  R. Tiwari,et al.  Japanese encephalitis: a review of the Indian perspective. , 2012, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  Tae Hee Lee,et al.  Potential Therapeutics Against Flaviviruses , 2012 .

[3]  R. Cortese,et al.  A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity , 2012, PloS one.

[4]  Li Huang,et al.  Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII. , 2012, Antiviral research.

[5]  Duncan R. Smith,et al.  Characterization of putative Japanese encephalitis virus receptor molecules on microglial cells , 2012, Journal of medical virology.

[6]  C. Nelson,et al.  Crystal Structure of the Japanese Encephalitis Virus Envelope Protein , 2011, Journal of Virology.

[7]  V. Ravi,et al.  Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line. , 2011, Virus research.

[8]  M. Regner,et al.  Pivotal Role of Antibody and Subsidiary Contribution of CD8+ T Cells to Recovery from Infection in a Murine Model of Japanese Encephalitis , 2011, Journal of Virology.

[9]  J. Smit,et al.  Flavivirus Cell Entry and Membrane Fusion , 2011, Viruses.

[10]  A. Amarilla,et al.  Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[11]  S. Harrison,et al.  Peptide Inhibitors of Flavivirus Entry Derived from the E Protein Stem , 2010, Journal of Virology.

[12]  R. Raut,et al.  Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies. , 2010, Journal of virological methods.

[13]  S. Harrison,et al.  Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate , 2010, PLoS pathogens.

[14]  Yen-Liang Chen,et al.  Strategies for development of Dengue virus inhibitors. , 2010, Antiviral research.

[15]  B. Geiss,et al.  Focus on flaviviruses: current and future drug targets. , 2009, Future medicinal chemistry.

[16]  E. Jacoby,et al.  A Small-Molecule Dengue Virus Entry Inhibitor , 2009, Antimicrobial Agents and Chemotherapy.

[17]  Nagasuma Chandra,et al.  Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. , 2009, Virology.

[18]  Y. Modis,et al.  Crystal Structure of Dengue Virus Type 1 Envelope Protein in the Postfusion Conformation and Its Implications for Membrane Fusion , 2009, Journal of Virology.

[19]  Paul R. Young,et al.  Identification of novel target sites and an inhibitor of the dengue virus E protein , 2009, J. Comput. Aided Mol. Des..

[20]  R. Kuhn,et al.  Closing the door on flaviviruses: entry as a target for antiviral drug design. , 2008, Antiviral research.

[21]  V. Ravi,et al.  Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin , 2008, International Journal of Antimicrobial Agents.

[22]  Wei-June Chen,et al.  Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. , 2008, Virology.

[23]  D. Sriram,et al.  N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo , 2008, Virology Journal.

[24]  M. Diamond,et al.  Identification of Novel Small-Molecule Inhibitors of West Nile Virus Infection , 2007, Journal of Virology.

[25]  K. Löhr,et al.  Yellow fever virus NS3 protease: peptide-inhibition studies. , 2007, The Journal of general virology.

[26]  S. Liao,et al.  Japanese encephalitis virus infection stimulates Src tyrosine kinase in neuron/glia , 2007, Neuroscience Letters.

[27]  Alka,et al.  Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice , 2007, Medical Microbiology and Immunology.

[28]  Ashish,et al.  Antiviral Peptides Targeting the West Nile Virus Envelope Protein , 2006, Journal of Virology.

[29]  E. Turpin,et al.  Inhibition of Influenza Virus Infection by a Novel Antiviral Peptide That Targets Viral Attachment to Cells , 2006, Journal of Virology.

[30]  Y. Modis,et al.  Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes , 2006, Journal of Virology.

[31]  D. A. Stein,et al.  Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. , 2006, Virology.

[32]  T. Oliphant,et al.  Structural basis of West Nile virus neutralization by a therapeutic antibody , 2005, Nature.

[33]  Scott F Michael,et al.  Peptide inhibitors of dengue virus and West Nile virus infectivity , 2005, Virology Journal.

[34]  D. A. Stein,et al.  Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication , 2005, Journal of Virology.

[35]  M. Ng,et al.  Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. , 2005, The Journal of general virology.

[36]  D. Gubler,et al.  Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses , 2004, Nature Medicine.

[37]  Timothy S Baker,et al.  Conformational changes of the flavivirus E glycoprotein. , 2004, Structure.

[38]  K. Stiasny,et al.  Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.

[39]  Y. Modis,et al.  Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.

[40]  Yun-Liang Yang,et al.  Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli. , 2003, Biochemical and biophysical research communications.

[41]  T. Solomon.  Exotic and emerging viral encephalitides. , 2003, Current opinion in neurology.

[42]  F. Heinz,et al.  The machinery for flavivirus fusion with host cell membranes. , 2001, Current opinion in microbiology.

[43]  R. Chen,et al.  Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. , 2000, Vaccine.

[44]  N. M. Dung,et al.  NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitis , 2000 .

[45]  A. Barrett,et al.  Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants. , 1998, Virology.

[46]  P. McMinn.  The molecular basis of virulence of the encephalitogenic flaviviruses. , 1997, The Journal of general virology.

[47]  S. Ritchie,et al.  An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995 , 1996, Medical Journal of Australia.

[48]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[49]  T. Matsuishi,et al.  Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. , 1992, Pediatric neurology.

[50]  A. Nisalak,et al.  Japanese encephalitis: Immunocytochemical studies of viral antigen and Inflammatory cells in fatal cases , 1985, Annals of neurology.

[51]  J. H. Strauss,et al.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. , 1985, Science.

[52]  Chen Li,et al.  Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein. , 2013, Virus research.

[53]  Springer-Verlag Wien.  Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo , 2013 .

[54]  P. Zhao,et al.  Association of heat-shock protein 70 with lipid rafts is required for Japanese encephalitis virus infection in Huh7 cells. , 2012, The Journal of general virology.

[55]  J. Chin,et al.  The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. , 2007, Microbes and infection.

[56]  Charles M. Rice,et al.  Flaviviridae :T he Viruses and Their Replication , 2007 .

[57]  A. Budak.  [Japanese encephalitis]. , 1975, Fel'dsher i akusherka.